相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus
Timothy B. Niewold et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
The stable traits of melanoma genetics: an alternate approach to target discovery
Tara L. Spivey et al.
BMC GENOMICS (2012)
A genetic inference on cancer immune responsiveness
Ena Wang et al.
ONCOIMMUNOLOGY (2012)
The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype
Karen Dawidowicz et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection
K. Vandenbroeck et al.
GENES AND IMMUNITY (2011)
Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis
Tara L. Spivey et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
An immunologic portrait of cancer
Maria Libera Ascierto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
The type I interferon system in the etiopathogenesis of autoimmune diseases
Lars Ronnblom
UPSALA JOURNAL OF MEDICAL SCIENCES (2011)
CD8+ Enriched Young Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma
Mark E. Dudley et al.
CLINICAL CANCER RESEARCH (2010)
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Mark E. Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations
G. Kristjansdottir et al.
JOURNAL OF MEDICAL GENETICS (2008)
Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines
Rosa Mendez et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
An insertion-deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases
Vinciane Dideberg et al.
HUMAN MOLECULAR GENETICS (2007)
Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus
Robert R. Graham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Systemic lupus erythematosus: all roads lead to type I interferons
Virginia Pascual et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus
RR Graham et al.
NATURE GENETICS (2006)
Prognostic significance of autoimmunity during treatment of melanoma with interferon
H Gogas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling
A Schoenemeyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
ME Dudley et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus
P Blanco et al.
SCIENCE (2001)
Melanoma-associated retinopathy: does autoimmunity prolong survival?
C Chan et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2001)
Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon α genes
BJ Barnes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
